News Results
There are 648,255 News Results
Oct 3, 2017
PALM BEACH, Florida, October 4, 2017 /PRNewswire/ -- Bitcoin and other cryptocurrencies have been on a tear for most of this year as focus has turned to the advancements and...
Oct 3, 2017
- Dr. Leonard Post, Dr. Eric J. Brown, and Dr. Geoffrey I. Shapiro to discuss DDR scientific and clinical development - VANCOUVER, Oct. 4, 2017 /PRNewswire/ - Sierra Oncology, Inc....
Oct 9, 2017
WINTER PARK, Fla., Oct. 10, 2017 /PRNewswire/ -- Full Sail University is proud to announce the 2017 Full Sail University Hall of Fame induction class comprised of six graduates recognized...
Oct 10, 2017
DUBLIN, October 11, 2017 /PRNewswire/ -- The "3D Cell Cultures: Products, Technologies and Key Application Areas (2nd Edition), 2017-2030" report has been added to
Oct 15, 2017
STUTTGART, Germany, Oct. 16, 2017 /PRNewswire/ -- -- Plans for three legally independent entities under the roof and lead of Daimler AG -- Strengthening of the corporate structure will serve...
Oct 16, 2017
LONG BEACH, Calif., Oct. 17, 2017 /PRNewswire/ -- Epson, the number-one selling projector brand worldwide, today launched nine new PowerLite(®) long-throw projectors for K-12 classrooms. The new Epson PowerLite S39...
Oct 16, 2017
DALLAS, Oct. 17, 2017 /PRNewswire/ -- RSA, a global cybersecurity leader delivering Business-Driven Security(TM) solutions, unveiled new products to help address many of the challenges related to compliance with data...
Oct 16, 2017
SAN FRANCISCO, Oct. 17, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, is presenting data showing genetic sequencing and copy number variant (CNV)...
Oct 17, 2017
PALM BEACH, Florida, October 18, 2017 /PRNewswire/ -- Biotech Briefing: The Biotech Sector continues to impress and even surprise many as the SPDR S&P Biotech ETF (XBI) has surged 49...
Oct 22, 2017
SAN DIEGO, Oct. 23, 2017 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today...